New drug tested for rare Muscle-Wasting disease
Disease control
Completed
This study tested whether an investigational drug called NIDO-361 is safe and effective for adults with spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease. It involved 54 men with SBMA who were randomly assigned to receive either the drug or a placebo for …
Phase: PHASE2 • Sponsor: Nido Biosciences, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC